MedPath

ALTACE PLUS FELODIPINE 5MG + 5MG

ALTACE PLUS FELODIPINE 5MG + 5MG

Discontinued
DIN Number

02240306

Drug Class

Human

Market Date

Jun 27, 2006

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240306
AIG Number0237542001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09BB05 RAMIPRIL AND FELODIPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.04
Health Canada Classification

ACTIVE INGREDIENTS (2)

FELODIPINEActive
Strength: 5 MG
Monograph: FELODIPINE
RAMIPRILActive
Strength: 5 MG
Monograph: RAMIPRIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.